Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ipsogen.

Bertrand R Jordan1

  • 1Scientific Advisory Board, Ipsogen, Luminy Biotech Entreprises, Case 923, 163 Avenue de Luminy,13288 Marseille, France. jordan@genopole.univ-mrs.fr.

Personalized Medicine
|May 23, 2018
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Response to Busby.

Genetics·2016
Same author

The Hiroshima/Nagasaki Survivor Studies: Discrepancies Between Results and General Perception.

Genetics·2016
Same author

Is there a niche for DNA microarrays in molecular diagnostics?

Expert review of molecular diagnostics·2010
Same author

Whole-genome association studies for multigenic diseases: ethical dilemmas arising from commercialization--the case of genetic testing for autism.

Journal of medical ethics·2010
Same author

Cloning and sequencing the first HLA gene.

Genetics·2010
Same author

DNA microarrays: from profiles to biology.

Pharmacogenomics·2008
Same journal

The impact of the rise of the chatbots: transforming genetics clinical delivery and research.

Personalized medicine·2026
Same journal

Digital biomarkers in chronic disease management: a systematic review of personalization and ethical challenges.

Personalized medicine·2026
Same journal

Toward a harmonized assessment of MRD by NGS: blinded pilot study of NGS assays by MPAACT consortium.

Personalized medicine·2026
Same journal

Expression levels of microRNA-550a-5p in patients with spinal metastases from non-small cell lung cancer.

Personalized medicine·2026
Same journal

Epigenetic and genetic insights for tailored therapeutic strategies in multiple sclerosis.

Personalized medicine·2026
Same journal

Deciphering the multi-organ anti-fibrotic mechanisms of pirfenidone and nintedanib via network pharmacology.

Personalized medicine·2026
See all related articles

Ipsogen develops innovative molecular diagnostic tests for personalized cancer treatment. Their expertise in gene expression profiling aids in guiding treatment decisions for blood and breast cancers.

Area of Science:

  • Molecular diagnostics
  • Oncology
  • Genomics

Background:

  • Personalized medicine is revolutionizing cancer care.
  • Accurate diagnostics are crucial for effective treatment selection.
  • Ipsogen has established a global presence in cancer diagnostics.

Purpose of the Study:

  • To develop and commercialize innovative diagnostic tests for cancer.
  • To guide and personalize treatment options for cancer patients.
  • To translate scientific discoveries into industry-standard diagnostic tools.

Main Methods:

  • Large-scale gene expression profiling of tumors.
  • Development of DNA and RNA tests for blood cancers.
  • Expression profiling and interpretation for breast cancer using extensive studies.
Keywords:
bioinformaticsblood cancersbreast cancerexpression profilingmolecular diagnosticsoncogenomics

Related Experiment Videos

Main Results:

  • A comprehensive portfolio of blood cancer diagnostic products.
  • Worldwide availability of tests to leading cancer care institutions in over 50 countries.
  • Established know-how in translating discoveries into diagnostic tools.

Conclusions:

  • Ipsogen's products and services enable personalized cancer treatment.
  • Gene expression profiling is key to guiding therapeutic strategies.
  • The company's diagnostics facilitate effective and individualized cancer care.